Angiogenesis and Breast Cancer

Overview

Journal J Oncol

Specialty Oncology

Date 2010 Oct 19

PMID 20953378

Citations 57

Authors

Adhemar Longatto Filho

Jose Manuel Lopes

Fernando C Schmitt

Affiliations

Soon will be listed here.

Abstract

Angiogenesis is an essential step for breast cancer progression and dissemination. The development of new blood vessels in cancer setting (angiogenesis) is conducted by numerous physiological and pathological stimuli, where the main stimulus is hypoxia. The knowledge of different molecular pathways regulating angiogenesis is constantly growing. An increased and complex scenario of angiogenesis is nowadays available in breast cancer, specifically, and permits not only to understand most of the important phases of neoplastic growth but also offer an exciting perspective for new therapeutic proposals based on blocking new blood vessels sprouting. This review focused on historical and recent understanding of angiogenesis occurrence in breast cancer.

Citing Articles

Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials.

Mehta K, Hegde M, Girisa S, Vishwa R, AlQahtani M, Abbas M Mil Med Res. 2024; 11(1):76.

PMID: 39668367 PMC: 11636053. DOI: 10.1186/s40779-024-00582-z.

Molecular docking and / studies of a novel thiadiazole Schiff base as a hepatoprotective drug against angiogenesis induced by breast cancer.

Alqahtani N, Alfaifi M, Shati A A, Elbehairi S, Saleh A, Kotb E RSC Adv. 2024; 14(52):39027-39039.

PMID: 39659603 PMC: 11629753. DOI: 10.1039/d4ra06398h.

Vascular Endothelial Growth Factor Expression by Immunohistochemistry as a Possible Indicator of Prognosis in Invasive Breast Carcinoma of No Special Type.

Sindhura N, Kaumudi K Int J Appl Basic Med Res. 2024; 14(2):124-130.

PMID: 38912361 PMC: 11189271. DOI: 10.4103/ijabmr.ijabmr_17_24.

Regional analysis to delineate intrasample heterogeneity with RegionalST.

Lyu Y, Wu C, Sun W, Li Z Bioinformatics. 2024; 40(4).

PMID: 38579257 PMC: 11026142. DOI: 10.1093/bioinformatics/btae186.

Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma-Induced Hepatic Damage in Mice.

Alamoudi J, El-Masry T, Nasr M, Ibrahim I, Ibrahim H, Saad H Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256929 PMC: 10820129. DOI: 10.3390/ph17010096.

References

Rosen L, Ashurst H, Chap L . Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review. Oncologist. 2010; 15(3):216-35. PMC: 3227950. DOI: 10.1634/theoncologist.2009-0145. View

Smith N, Baker D, James N, Ratcliffe K, Jenkins M, Ashton S . Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers. Clin Cancer Res. 2010; 16(14):3548-61. DOI: 10.1158/1078-0432.CCR-09-2797. View

Ferrara N . Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 2009; 29(6):789-91. DOI: 10.1161/ATVBAHA.108.179663. View

Tsutsui S, Inoue H, Yasuda K, Suzuki K, Takeuchi H, Nishizaki T . Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density. Breast Cancer Res Treat. 2006; 98(3):261-6. DOI: 10.1007/s10549-005-9157-9. View

Luo Y, Zhou H, Mizutani M, Mizutani N, Reisfeld R, Xiang R . Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine. Proc Natl Acad Sci U S A. 2003; 100(15):8850-5. PMC: 166402. DOI: 10.1073/pnas.1033132100. View

Pinto M, Badtke M, Dudevoir M, Harrell J, Jacobsen B, Horwitz K . Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer. Cancer Res. 2010; 70(7):2655-64. PMC: 2848872. DOI: 10.1158/0008-5472.CAN-09-4373. View

Kerbel R . Tumor angiogenesis. N Engl J Med. 2008; 358(19):2039-49. PMC: 4542009. DOI: 10.1056/NEJMra0706596. View

Zhou D, Cheng S, Ji H, Wang J, Xu H, Zhang G . Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer. J Cancer Res Clin Oncol. 2010; 136(11):1719-27. DOI: 10.1007/s00432-010-0830-y. View

Pavlakis K, Messini I, Vrekoussis T, Yiannou P, Keramopoullos D, Louvrou N . The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions. BMC Cancer. 2008; 8:88. PMC: 2323394. DOI: 10.1186/1471-2407-8-88. View

10.

Kawai H, Li H, Chun P, Avraham S, Avraham H . Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Oncogene. 2002; 21(50):7730-9. DOI: 10.1038/sj.onc.1205971. View

11.

Mumprecht V, Detmar M . Lymphangiogenesis and cancer metastasis. J Cell Mol Med. 2009; 13(8A):1405-16. PMC: 3572232. DOI: 10.1111/j.1582-4934.2009.00834.x. View

12.

Greenberg S, Rugo H . Triple-negative breast cancer: role of antiangiogenic agents. Cancer J. 2010; 16(1):33-8. DOI: 10.1097/PPO.0b013e3181d38514. View

13.

Wulfing P, Tio J, Kersting C, Sonntag B, Buerger H, Wulfing C . Expression of endothelin-A-receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer. 2004; 91(3):434-40. PMC: 2409854. DOI: 10.1038/sj.bjc.6601889. View

14.

Rennel E, Varey A, Churchill A, Wheatley E, Stewart L, Mather S . VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Br J Cancer. 2009; 101(7):1183-93. PMC: 2768092. DOI: 10.1038/sj.bjc.6605249. View

15.

Weidner N, Semple J, Welch W, Folkman J . Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med. 1991; 324(1):1-8. DOI: 10.1056/NEJM199101033240101. View

16.

Albuquerque R, Hayashi T, Cho W, Kleinman M, Dridi S, Takeda A . Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med. 2009; 15(9):1023-30. PMC: 2882165. DOI: 10.1038/nm.2018. View

17.

Chhieng D, Tabbara S, Marley E, Talley L, Frost A . Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma. Breast J. 2003; 9(3):200-7. DOI: 10.1046/j.1524-4741.2003.09311.x. View

18.

Folkman J, Merler E, Abernathy C, Williams G . Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 1971; 133(2):275-88. PMC: 2138906. DOI: 10.1084/jem.133.2.275. View

19.

Wulfing P, Kersting C, Tio J, Fischer R, Wulfing C, Poremba C . Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. Clin Cancer Res. 2004; 10(7):2393-400. DOI: 10.1158/1078-0432.ccr-03-0115. View

20.

Bando H . Vascular endothelial growth factor and bevacitumab in breast cancer. Breast Cancer. 2007; 14(2):163-73. DOI: 10.2325/jbcs.968. View